Bala Venkatesh is Director of Intensive care at the Wesley Hospital, Pre-Eminent specialist in Intensive Care Medicine at the Princess Alexandra Hospital, Brisbane, Professor of Intensive Care Medicine at the University of Queensland, and. at the University of New South Wales, and Professorial Fellow at the George Institute for Global Health, Sydney Australia. He is the Chairman of the Queensland Health Statewide Sepsis Steering Committee. He is a Fellow of the Australian Academy of Health and Medical Sciences

He has completed Fellowship training in Internal Medicine, Anaesthesia and Intensive Care Medicine.  He then undertook a research degree from the University of Birminghan, UK which led to the award of an MD.  He pioneered the development of a continuous blood gas monitoring system which reached clinical application.

He served as the President for the College of Intensive Care Medicine of Australia and New Zealand between 2014-2016.  He led the international taskforce on gender equity in Intensive Care which influenced guidelines in the World federation of Intensive Care. As President of the College of Intensive Care, he led the task force on bullying and discrimination which have informed College policy.

He led the NHMRC funded multi-center international ADRENAL trial which is largest septic shock trial to date. This was published in the New England Journal of Medicine and ranked in the top 12 articles of 2018. He has served on several  Data Safety Monitoring Committees and on the Management committee of RCTs in sepsis. His research interests include glucocorticoid physiology in critical illness including the development of the idea of the "sick euadrenal state, sepsis and vitamin D in critical illness.

In 2020, following the Covid-19 pandemic, he contributed to the REMAP-CAP steroid trial design and development and was on its writing committee recently reported in JAMA, which influenced guideline development. He was instrumental in the development of the George Institute’s Covid-19 research program in India and played a  key role in the set up of the COVID Steroid 2 trial in India which was also published in JAMA. He is currently investigating the role of fludrocortisone in septic shock.

He has published more than 250 papers, 40 book chapters, and edited 2 books. He has supervised 8 PhD students. He is now a Level 3 NHMRC Investigator Fellow.

Professorial Fellow in the Critical Care Division at The George Institute for Global Health, Adjunct Professor, University of New South Wales and Professor of Critical Care, School of Public Health, Imperial College London.  

Simon leads the Sepsis Research Program at The George Institute which is focussed on the design and conduct of robust high-quality RCTs that will reduce death and disability due to sepsis in Australia and around the world.

Simon has obtained over $50M in research funding and authored or co-authored over 250 peer-reviewed papers with 20% of those in the highest-ranking medical journals. He served as a guest editor for the New England Journal of Medicine from 2012 to 2014 and is currently an editor of the Oxford Textbook of Critical Care and the Critical Care Section Editor of the Oxford Textbook of Medicine.

Simon was a founding member and is a past-Chair of the Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group, past chair of the International Sepsis Forum, and past Vice President of the Global Sepsis Alliance. He is the Director of the Australian Sepsis Network and Asia Pacific Sepsis Alliance.

A Fellow of the Australian Academy of Health and Medical Sciences, Simon was appointed an Officer (AO) in the Order of Australia in the Queen’s Birthday Honours List 2020 for “distinguished service to intensive care medicine, to medical research and education, and to global health institutes”

Dr Serena Knowles is the Program Manager for the Critical Care Program at The George Institute for Global Health. Serena supports the Program Head and Program Lead in managing all aspects of the Critical Care program, including operational activities, business administration, management of grant applications and program strategy and development.

Serena is a nurse researcher, with over 15 years of clinical critical care experience and over 14 years of research experience. Serena completed her PhD in 2016 investigating the use of an evidence-based implementation strategy to effect clinician behaviour change and to improve clinical practice in the area of bowel management within the intensive care unit. Prior to working at TGI, she worked as a Research Coordinator for ICU and neurology trials. Since working at TGI, she has worked in numerous roles, including Clinical Research Associate, Project Manager, and Operations Lead. She is the current Co-Convener for the Point Prevalence Program, a collaboration between TGI and the Australian and New Zealand Intensive Care Society. 

Serena has an interest in process evaluation and implementation science.

Manoj continues to practise as an Intensive Care Physician and is based part-time at St. George Public Hospital in Sydney, playing a key role in the intensive care research program with Professor John Myburgh.

His postgraduate qualifications include Fellowship of both the Royal College of Physicians in the United Kingdom and Australia and Fellowship of the College of Intensive Care Medicine.

Research interests include large scale clinical observational and randomised trials.  Further specific areas of research interest include the role of fever in severe infections and acute brain injury, Intensive Care Unit Acquired Weakness and Early Mobility, and Outcome Evaluation in Critical Care Medicine research.

Dorrilyn Rajbhandari is a Senior Project Manager at the George Institute for Global Health. She is chair of the Project Manager Interest Group, and a member of the ANZICS Clinical Trial Group. As a Senior Project Manager, with many years of experience as a nurse clinician in intensive care research, she has vast experience in clinical trial management, operationalisation of protocols, including protocol development and design, CRF design, website and data management, multiple sub-studies, final analysis and resulting publications. She is a resource and mentor for colleagues.

Dorrilyn has successfully coordinated and managed many multi-centre, worldwide clinical trials in intensive care. She has successfully completed, within expected timelines, the CHEST study (7000 patients), ADRENAL study, a 3,800 patient study from 70 sites worldwide, including the ADRENAL-GEPS Sub-Study, with the largest severe sepsis cohort in precision medicine. The process provided experience in drug manufacture, regulatory requirements and regulatory approvals in multiple countries including importation and exportation processes and requirements, sample collections and transfers from around the world. Dorrilyn is currently project managing a number of studies; BLING III multicentre clinical outcome study, a 7000 patient study from 100 sites around the world. FluDReSS, a 300 patient study from 10 sites. HOPE, hydroxycholoquine prophylaxis in health care workers in India. 

Dorrilyn Rajbhandari has the expertise to implement, manage and complete efficiently within timelines, large multi-centre clinical trials with results published in high quality journals.

Anthony Delaney is a father of three and husband to a multi-talented anaesthetist. He is a Fellow of the Australasian College for Emergency Medicine and the College of Intensive Care Medicine. He is a Professorial Fellow in the Division of Critical Care at the George Institute for Global Health, also holding appointments as Associate Professor at Sydney Medical School, University of Sydney and an adjunct Associate Professor at the Australian and New Zealand Intensive Care Research Centre, in the Department of Epidemiology and Preventative Health at Monash University. He maintains a clinical role as Senior Staff Specialist in the Malcolm Fisher Department of Intensive Care Medicine at The Royal North Shore Hospital.

Associate Professor Delaney’s major research interests are centred on improving methods of resuscitation of patients with sepsis and septic shock and improving outcomes for patients suffering acute severe brain injuries.

Professor Craig Anderson is Professor of Neurology and Epidemiology, Faculty of Medicine, UNSW Sydney, and is in part-time clinical practice as a neurologist at Royal Prince Alfred Hospital, Sydney, Australia.  

Craig holds specialist qualifications in clinical neurology and geriatrics, a PhD in medicine and epidemiology from The University of Western Australia, and is a Senior Investigator Fellow of the National Health and Medical Research Council (NHMRC) of Australia.  He is a past President of the Asia Pacific Stroke Organisation and the Stroke Society of Australasia, and is a member of several specialist societies and an editor for the Cochrane Stroke Group.  He has published widely on the clinical and epidemiological aspects of stroke, cardiovascular disease and aged care, and has led several large-scale investigator-initiated epidemiological and clinical trials that have had a major influence on clinical practice guidelines for stroke treatment and prevention.

Associate Professor Naomi Hammond is the Critical Care Program Head at The George Institute for Global Health. She also works part-time as the Intensive Care Clinical Research Manager at Royal North Shore Hospital, Sydney, Australia. Naomi holds several other appointments including NHMRC Emerging Leader Fellow; Conjoint Associate Professor at the Faculty of Medicine, University of New South Wales; an Editorial Board Member for Australian Critical Care Journal; Chair of the Australian Critical Care Nurses Research Advisory Panel; and Senior Research Fellow with the Australian Sepsis Network.

Naomi is a clinical nurse researcher and has led a program of sepsis research through international collaborations including facilitating 4 clinical trials in COVID-19 in India.  She leads the Australian and New Zealand Intensive Care Society Point Prevalence program. She has also undertaken international point prevalence studies including a large epidemiological study of patients with sepsis in Indian ICUs. Called the SIPS (Sepsis in India Prevalence) study, it has provided vital insights into changing epidemiology with different sepsis definitions, bacteriology, and antimicrobial resistance patterns.

Naomi’s main research interests include fluid resuscitation, sepsis, fever management, knowledge translation and implementation research, health economics, and long-term outcomes post-critical illness. Naomi has experience supervising and mentoring medical trainees, nursing staff, PhD, Masters and medical students in both the clinical and academic environment.

Additional to Naomi’s academic portfolio, she also has extensive clinical trials operational management experience including finance, regulatory processes, personnel, project and program management in a clinical and NGO environment.